Welcome to OncologyPRO, the home of Esmo’s educational and scientific resources.

The CAPTURE study has characterised functional immune responses in people with cancer following SARS-CoV-2 infection or vaccination

People with colorectal cancer liver cancer metastases that have progressed may benefit from second-line trans-arterial Yttrium-90 radioembolisation

Most solid tumour patients recently given chemotherapy and/or immunotherapy will achieve an adequate antibody response to COVID-19 vaccination

Study findings suggest that drug-free intervals during sunitinib or pazopanib treatment may be acceptable for patients with advanced clear cell renal cell carcinoma

Combining osimertinib with bevacizumab has not improved the outcomes of advanced nonsquamous non-small-cell lung cancer patients with EGFR activating mutations

Children and adults with PIK3CA-related overgrowth spectrum experienced improvements in lesions and symptoms following treatment with alpelisib

Nodal burden may help identify patients with resected stage III non-small-cell lung cancer who may derive some benefit from postoperative conformal radiotherapy

Adding carboplatin to neoadjuvant chemotherapy improves event-free survival for triple-negative breast cancer patients